CVS Health Co. (NYSE:CVS) Stock Holdings Trimmed by Trustmark National Bank Trust Department

Trustmark National Bank Trust Department reduced its holdings in CVS Health Co. (NYSE:CVS) by 36.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,737 shares of the pharmacy operator’s stock after selling 5,062 shares during the period. Trustmark National Bank Trust Department’s holdings in CVS Health were worth $549,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health during the 3rd quarter valued at $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the third quarter valued at approximately $31,000. Reston Wealth Management LLC bought a new stake in shares of CVS Health in the third quarter valued at approximately $32,000. First Community Trust NA lifted its stake in CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. bought a new position in shares of CVS Health in the 3rd quarter valued at $33,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

CVS opened at $57.07 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a 50 day simple moving average of $59.20 and a two-hundred day simple moving average of $58.60. CVS Health Co. has a 1-year low of $52.71 and a 1-year high of $83.25. The firm has a market cap of $71.81 billion, a P/E ratio of 14.48, a PEG ratio of 0.94 and a beta of 0.55.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the business earned $2.21 EPS. Equities analysts forecast that CVS Health Co. will post 5.43 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.66%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is currently 67.51%.

Analyst Ratings Changes

Several equities analysts recently weighed in on CVS shares. Mizuho dropped their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Barclays cut their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Evercore ISI boosted their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Finally, TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $59.00 to $85.00 in a report on Friday, October 4th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $72.28.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.